Condition
Eicosapentaenoic Acid
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04216251Phase 1Completed
PRevention Using EPA Against coloREctal Cancer
NCT05267301Phase 4Completed
AlmegaPL CV Health Open Label Study
NCT04743050Phase 3Unknown
The ALA, DHA and EPA Esters in the Prevention of Cardiovascular Diseases.
NCT01692431Not ApplicableCompleted
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
Showing all 4 trials